Myelodysplastic disorders with hemizygous M-CSF receptor gene loss do not show point mutations of codon 969 within the remaining allele.
Главные авторы: | Jaquet, K, Kreipe, H, Felgner, J, Boultwood, J, Parwaresch, MR |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
1993
|
Схожие документы
-
Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
по: Boultwood, J, и др.
Опубликовано: (1991) -
Loss of X-linked Protocadherin-19 differentially affects the behavior of heterozygous female and hemizygous male mice.
по: Hayashi, S, и др.
Опубликовано: (2017) -
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
по: Boultwood, J, и др.
Опубликовано: (2014) -
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
по: Bernard, E, и др.
Опубликовано: (2020) -
Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
по: Pellagatti, A, и др.
Опубликовано: (2016)